ABSTRACT Background: The interstitial fluid of the human myocardium was monitored in 13 patients
INTRODUCTION
A better understanding of the regulation of delivery and uptake of nutrients in the heart is required in order to optimize myocardial metabolic balance during cardioplegia. Research in this area has mainly focused on the pre-and immediately postoperative situations and various studies on plasma sampling techniques have been published (1, 5, 17) , including single and multiple-isotope balance studies (24, 38, 44) . Some (5, 36, 37, 39) , but not all investigators (31) , have demonstrated decreased cardiac uptake and oxidation of glucose and lactate in the initial postoperative period.
However, a more detailed knowledge is required of how the concentration of nutrients is regulated in the myocardium where interstitial fluid shifts are brought about by perfusion of cardioplegic solutions. A key issue is the monitoring of the myocardial metabolism during the cardioplegic period during which relevant plasma sampling can not be carried out. Sampling of the interstitial fluid of the myocardium by means of microdialysis before, during and after open-heart surgery is now used also in the clinical situation (18, 19) . When properly calibrated, the approach offers high-precision data from the myocardial interstitium (26) . The technique has previously been used for metabolic balance measurements in other organs (15, 14, 29) . Myocardial microdialysis has been performed in experimental setups, both of the calibrated (25) and of the non-calibrated type (20) . Non-calibrated microdialysis sampling of the human heart during cardioplegia was recently reported from two different centers (18, 19, 9) .
In the present study, we used internal reference calibration for measurement of interstitial glucose and lactate in the myocardium. Glucose and lactate were chosen as both being important nutrients for the myocardium during normal conditions. Increased lactate production serves as a marker for ischemia in the heart. Thirteen patients were monitored 4 before, during and after open-heart surgery, including hypothermic cardiopulmonary bypass and cold potassium cardioplegia, in an attempt to establish whether (1) the transcapillary diffusion is a rate-limiting step for myocardial glucose uptake before, or after, cardioplegia;
and (5) glucose is lowered and/or lactate increased to a critical extent during cold cardioplegia.
PATIENTS, MATERIALS AND METHODS

Patients
Thirteen patients of Caucasian origin, three females and ten males, mean age 62 years (range 33 -77years) ( Table 1) gave their informed consent to participate in the study, which was approved by the local ethics committee. No high-risk patients (i.e. patients with cerebral lesions, renal insufficiency or recent myocardial infarction) were included in the study. The ejection fraction (EF) was evaluated with echocardiography and/or angiography, and patients with an EF of < 35 % were excluded from the study, as were known cases of diabetes mellitus. Four patients (all males) underwent coronary artery by-pass surgery (CABG), including 1-4 distal anastomoses. Three of these received a left internal mammary artery (LIMA) graft to the left anterior descending (LAD) coronary artery. One of the CABG patients also underwent aortic valve replacement. In another patient, the CABG was an elective reoperation. Nine patients (three females, six males), received valve prosthesis because of aortic valve disease. Acetylsalicylic acid, warfarin and digoxin medications were discontinued preoperatively. In the patients from the CABG group, the dose of selective ß-blockers was reduced by 50% postoperatively and anti-angina medication was discontinued.
In the valve group, diuretics were reduced or discontinued postoperatively. The microdialysis probes were inserted in the region between the left anterior descending artery (LAD) and the second diagonal artery immediately following a full median sternotomy (18, 19, 20) . Care was taken to avoid vessels and to place the probes at equal depth (viz. 2 -3 mm). The patients were heparinized (300 U/kg body weight plus 7500 U heparin) prior to instituting by-pass. The anticoagulation was reversed with protamine (1 mg/100 U of heparin) after weaning from by-pass. The hearts were cannulated, either with a two-stage venous cannula in the right atrium (CABG group) or via bicaval cannulation (valve group). After aortic cross-clamping, the hearts were arrested with cold (2 -4 °C) crystalloid glucose-free cardioplegic solution (PlegisolÒ, Abbott Laboratories, North Chicago, IL, USA needed seven defibrillations to convert to sinus rhythm. After declamping, a mean reperfusion period of 23 min (range 12-39 min) was allowed before weaning off the by-pass. Weaning off by-pass was routinely done at a core temperature of 36°C if reperfusion was considered sufficient, otherwise longer reperfusion was allowed. Glucose (5%) solutions were used for the administration of parenteral drugs peroperatively and for up to 9 h after surgery.
Postoperatively, the patients were monitored according to the clinical routine, including continuous ECG, arterial and central venous pressures and pO 2 measurements. The patients were extubated within 4 h postoperatively. In case of extended drainage from the chest tubes, as with patient No. 1, the tracheal tube remained in place for longer. This patient underwent resurgery on the first postoperative day due to diffuse bleeding unrelated to the microdialysis probe. Coronary sinus catheters were removed no later than the morning after surgery. In patient No. 13, the coronary sinus catheter was extracted a few hours postoperatively due to ventricular fibrillation cured by defibrillation. However, since arrhythmia persisted after its removal, the catheter was not thought to be the cause.
The microdialysis probes were extracted percutaneously (18, 19) no later than 48 h after surgery. With few exceptions, the patients could start intake of fluids and some food on the first postoperative day. Three patients had short spells of atrial fibrillation postoperatively;
patient No. 1 had persistent atrial fibrillation during admission. Patients Nos. 1 and 7 showed transient ST segment alterations postoperatively. However, plasma markers for myocardial 8 ischemia, such as aspartate aminotransferase (ASAT) and creatine kinase MB (CK-MB) were insignificantly elevated and no case of myocardial infarction was diagnosed.
Microdialysis
The microdialysis probes were developed and manufactured in our laboratory (18, 19, 20) . The permeable membrane (0.6 mm outer diameter, 0.1mm pores) (CPC/PE, Gambro, Lund, Sweden) allowed passage of molecules exceeding the size of the markers used. The probes were perfused with sterile, isotonic NaCl solution at room temperature, at 2.5ml/min. Priming of the probes, to evacuate the air began not later than 20 min prior to implantation. Sampling was done before cardioplegia, at 10-min intervals during cardioplegia and reperfusion and thereafter, at 60-min intervals. Samples were stored at -80° C until analysis.
In situ calibration was performed with internal reference technique (27 way, recalibration data were achieved during the fluid shifts and temperature changes expected during the period. The loss of radioactivity over the microdialysis membrane was 9 used to calculate relative recovery. Continuous perfusion with internal reference markers was avoided, in order to prevent accumulation of the label in ambience of the catheter (27) . Data were corrected for the delay due to passing the dead space. Due to the variation in duration of the cardioplegia, data are presented as mean interstitial glucose and lactate concentrations in samples collected during the first 10 min after the onset of cardioplegia, as well as in samples representing the middle of the whole cardioplegic period and just before release of the aortic clamp.
Blood samples
Arterial blood was drawn from the radial or femoral artery and venous blood from the coronary sinus, both in the middle of microdialysis sampling periods (corrected for deadspace delay). The blood samples were centrifuged, and the plasma decanted and stored at -80°C.
Analyses
Glucose and lactate concentrations in plasma and dialysates were determined enzymatically using 10 µl samples for simultaneous analysis of glucose and lactate (YSI 2700 select biochemical analyzer, Yellow Springs Instruments Co., Yellow Springs, OH, USA).
Radioactivity was counted in a liquid scintillation counter with a quench-corrected (external standards), double-isotope program (1900 CA, TRI-CARB, Packard Instruments, Meriden, CA, USA).
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Statistics
The results are expressed as mean ± SE. Significance of difference was tested with ANOVA and, when appropriate Student´s t-test for paired and unpaired observations. A difference of P<0.05 was considered statistically significant.
RESULTS
There were no infections, infarctions, local bleeding or other complications related to the study. The microdialysis probes were implanted and extracted without inducing arrhythmias or other side-effects. Blood glucose increased approximately 1 h after surgery, since infusions containing glucose were given peroperatively (Fig. 1a) . Glucose infusions were also given postoperatively. Consequently, the high blood glucose levels at 25 h and 35 h postoperatively were postprandial, in contrast to the levels recorded prior to cardioplegia (Fig. 1a) .
The relative recovery (dialysate concentration/interstitial concentration) of interstitial glucose and lactate before induction of cardioplegia was 28±7% and 31±7%, respectively (means ± SE). The recovery declined during cardioplegia to 20±2% and 16±6%, respectively but increased 25 h postoperatively to 43±7% and 45±6%, respectively.
Interstitial glucose decreased immediately and significantly after coronary instillation of glucose-free cardioplegic solution and remained low throughout cardioplegia (Fig. 1a) . It was then restored to precardioplegic levels at 1 h after release of the aortic clamp. Interstitial glucose decreased again, at 25 h and 35 h after surgery, to levels similar to those recorded during cardioplegia (Fig. 1a) .
FIG. 1A
Plasma lactate increased slightly postoperatively (Fig. 1b) . A statistically nonsignificant decrease in interstitial lactate was registered immediately at induction of cardioplegia followed by a significant increase throughout the clamping period (Fig. 1b) . The lowest levels of interstitial lactate were recorded 25h and 35 h after surgery.
FIG. 1B
The uptake and release of glucose and lactate in the myocardium were calculated from the differences between the arterial-coronary sinus (AV) and arterial-interstitial (AI)
concentrations. There was a significant uptake of glucose before cardioplegia ( Table 2 ). Both the AV and the AI concentration differences for glucose increased significantly postoperatively. Throughout the recording period, interstitial glucose was lower than both arterial and venous blood glucose (Fig. 1a) and therefore, the AI concentration differences of glucose exceeded the corresponding AV differences (Table 2) .
Before cardioplegia, a small, but statistically significant AV difference was recorded for lactate, indicating a myocardial uptake (Table 2) . This switched to a significant negative lactate balance 1 h after cardioplegia. The AI difference for lactate increased significantly 25 h after surgery, indicating a significant rate of lactate utilization by the myocardium. 
DISCUSSION
To our knowledge, this is the first study in which calibrated microdialysis is used for direct measurement of nutrient concentrations in the interstitium of the human heart. The results
show that: 1) there are significant differences in AI concentration differences for both glucose and lactate in the beating heart, indicating that transcapillary diffusion is a rate-limiting step for both the uptake and the release of glucose and lactate; and (5) interstitial glucose and lactate levels change during cardioplegia but never reach non physiological concentrations.
Before cardioplegia
Interstitial glucose in the myocardium was only ~ 50% of that in arterial plasma, indicating that the entry of glucose into the interstitial fluid does not balance its rate of elimination.
Consequently, transcapillary diffusion of glucose in addition to the myocellular glucose transporter, is a rate-limiting step for myocardial glucose uptake. This is in agreement with findings in skeletal muscle in resting subjects, in which the glucose uptake rate correlates negatively to interstitial glucose concentration (12, 13) . In working skeletal muscle, blood flow and capillary permeability increase to reduce the concentration difference between arterial and interstitial glucose. The interstitial glucose concentration was surprisingly low, since the blood flow in the myocardium is much higher than in skeletal muscle which, in turn,
indicates that the cellular uptake of glucose in the myocardium is extremely efficient (5, 10,
41).
Small hydrophilic molecules exchange via passive diffusion through intercellular clefts in continous capillaries (4) . Thus, the extraction fraction (ExF) for glucose and lactate can be calculated according to the formula: ExF = (A -I) · (I -e -PS/Q ), where A is the arterial concentration, I is the interstitial concentration, PS is the permeability surface area product 14 and Q is the flow of plasma (4). In our study, the AV-difference of glucose was 0.2 mmol/l and, hence, the resulting apparent PS/Q ratio in the myocardium could be approximated to 0.1 ml/100g/min. Assuming a plasma flow of 60 ml/min/100g (40), the apparent PS for glucose approximates 6 ml/100g/min and the glucose uptake, 20 umol/100g/min. This PS value is considerably lower than that previously reported for perfused animal heart preparations (4) and may indicate a reduced nutritional myocardial blood flow in our patients. Interestingly, despite normal coronary blood flow, myocardial glucose uptake is reduced to 40 umol/100g/min in patients with coronary heart disease (30). It is noteworthy, that the present results were obtained in 13 patients, four of whom had coronary heart disease and that the glucose balance was estimated during non-insulin-stimulated conditions. Hence, the low PS/Q ratio demonstrated in the present study indicates that capillary permeability was low in the patients currently investigated.
Our results suggest that coronary heart disease may not only be characterized by myocardial hypoxia due to reduced blood flow but also by restricted availability of nutrients and consequently reduced ATP levels in agreement with previous studies (21, 35) . The subject group presently investigated was small and, consequently, subgrouping of the subjects could not lead to any firm conclusion as to the nutrient availability in the four patients with coronary artery disease subjected to coronary by-pass surgery since they did not show lower interstitial glucose levels than did the rest of the patients (data not shown). In a previous and larger study we were able to compare data from patients with ischemic and non-ischemic heart disease (18, 19) . As expected, the patients with ischemic heart disease had more marked relative changes in the appearance of ischemic markers in the interstitial fluid perioperatively as compared with the subjects with non ischemic heart disease. It was noteworthy, however, that the concentration of substrates like nutritive amino acids did not differ between the 15 groups. It may, thus, be concluded that even if small differences may exist between different patients in this regard, larger study groups are required to give further evidence.
Interstitial lactate did not differ from plasma lactate, even though lactate was lower in venous plasma than in arterial plasma. However, lactate metabolism is not reflected by interstitial concentration measurements only (16) . An interstitial concentration of lactate higher than that in plasma does not rule out ongoing lactate uptake and oxidation since a net myocardial release of lactate may prevail simultaneously with lactate uptake and oxidation (24, 7, 43, 42) .
Furthermore, there are regional variations of lactate oxidation within the myocardium, when the left ventricle wall releases lactate more efficiently than do the other regions (7, 6) .
Therefore, we found no AI concentration difference for lactate in the wall of the left ventricle, whereas the AV concentration difference indicated myocardial uptake and oxidation of lactate.
During cardioplegia
It is notable that mean interstitial glucose, which was low throughout the cardioplegic period, was never lower than 1 mmol/l, despite repeated administration of glucose-free cardioplegic solution. Apparently, glucose was not totally depleted in spite of low or abolished glucose uptake under low temperature. Interstitial lactate also decreased initially and accumulated slowly during heart arrest, despite the intermittent perfusion with cardioplegic solution. The mean interstitial lactate levels did not exceed the precardioplegia levels during this period.
Since the glucose uptake was very low we conclude that the interstitial lactate is probably derived more from glycogen breakdown. Clearly, in our study this did not lead to exceedingly high interstitial levels of lactate (Fig. 1b) .
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Finally, it should be noted that since diffusion over the microdialysis membrane was reduced at lower temperatures, subsequent recalibrations were performed.
After cardioplegia
Interstitial glucose increased significantly immediately after release of the aortic cross-clamp whereas interstitial lactate remained high. Both AI and AV differences for glucose increased significantly, indicating enhanced glucose consumption. By contrast, lactate AI was negative, as a result of net myocardial release of lactate. The elimination and oxidation of glucose, as well as of lactate, were low during the early postoperative phase, as reported previously (36) .
Very high interstitial lactate concentrations were registered in two (No. 6 and 9) out of the four patients with coronary heart disease immediately after release of the cross-clamp (4 mM/L and 12 mM/L, respectively) (data not shown). This may be due to a previous upregulation of the glycolytic capacity.
At 25 h and 35 h after release of the cross-clamp, all patients displayed very low interstitial glucose and lactate, indicating high elimination and oxidation rates. This is in agreement with previous studies at 4 h (5) and 8 h (39) after surgery. In this late phase, patients with coronary heart disease had equally low interstitial glucose and lactate levels as did the other patients. It should be noted that the 25-h and 35-h samples were collected postprandially and, hence, blood glucose as well as plasma lactate, were high (Fig. 1) . The low interstitial levels therefore indicate a rapid elimination of glucose and lactate from the interstitial fluid into the myocardial cells.
Markers for ischemia accumulate in the interstitial fluid early during cardioplegia (19, 9) and are steadily released during reperfusion (9) . The present data do not indicate that the poor delivery of glucose or the lactate accumulation in the myocardium potentiates the trauma of cold cardioplegia (8) . In accordance, the addition of glucose and/or lactate to cardioplegic solutions has no convincing cardioprotective effect (2, 11, 33, 34) . Protection by other compounds such as alpha-ketoglutarate (22) and cocarboxylase (23) or by ischemic preconditioning (3) may be more efficient. The addition of adenosine to the cardioplegic solution or for pretreatment has not given conclusive effects so far (40, 28, 32) .
In summary, microdialysis may constitute a useful tool in the evaluation of cardioprotective measures during open-heart surgery. The results show that capillary delivery of glucose is a rate-limiting step for myocardial glucose uptake in the beating heart but not during cold cardioplegia. Furthermore, during cardioplegia, lactate has been found to accumulate in the interstitium but not at exceedingly high levels.
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